SCHEMBL6206205

SCHEMBL6206205

CCCC(O)c1noc(CC)n1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.33
ACACA Q13085 1/20 0.33
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5821817 0.84 PPARA (0.35)
SCHEMBL7655000 0.74 HSD11B1 (0.36) ACACBACACA
SCHEMBL14709918 0.72 ACACB (0.33) ACACBACACA
SCHEMBL5954975 0.71 KDM4E (0.33)
SCHEMBL2163672 0.71 KDM4E (0.33)
SCHEMBL10153351 0.68 HSD11B1 (0.31) ACACBACACA
SCHEMBL6124859 0.65
SCHEMBL5616028 0.64 ALDH1A1 (0.39)
SCHEMBL10094578 0.63 NPC1 (0.41)
SCHEMBL23591981 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515726-A1 MORPHOLINE AND TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2005-03-23 EP disclosed
WO-2004002491-A1 MORPHOLINE AND TETRAHYDROPYRAN DRIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2004-01-08 WO disclosed